OUR STORY
From Mapping the Asset to Governing the Enterprise.
Genomic AI began as an attempt to answer a narrow, practical question inside industrial cybersecurity: how do you know what a connected asset is actually doing, what it's allowed to do, and what touches it, at any given moment? The earliest internal language for that effort was blunt and mechanical — the team called it "mapping the DNA of a connected asset."
That phrase turned out to be more prophetic than anyone intended.
A Problem Born in Operational Technology.
NexGenomics's earliest technical lineage runs through industrial control systems and critical infrastructure — built to solve a stubbornly hard problem: enterprises couldn't reliably see, classify, or govern the full set of connections between their IT systems, their AI and analytics tools, and the physical control systems running plants, grids, and facilities.
The earliest discipline that would eventually become Genomic AI was a visibility and asset-inventory problem before it was an AI problem. But the shape of the solution — structured, provenance-carrying, continuously validated records of what a thing is and what it's allowed to do — was already the shape of everything NexGenomics builds today.
"We've come a long way. The early versions of this were us talking about mapping the DNA of a connected asset. Now it's the backbone of everything we build." — Francis Cianfrocca, Co-Founder & CEO, NexGenomics
From Asset Visibility to Data Governance.
As the underlying platform matured and moved beyond pure OT/ICS environments into SMB and mid-market use cases, the original DNA-mapping discipline generalized. An asset was no longer just a piece of industrial equipment with a network address — it was any unit of enterprise data: a record, a document, a sensor reading, a clinical note, a transaction. Each one needed the same thing the original effort had demanded of a connected asset: a structured identity, a provenance trail, and a governing policy determining what could be done with it and by whom.
The Insight: Genomic AI Is Born.
Genomic AI, as both a term and an architectural approach, was conceived and developed by Francis Cianfrocca, with a patent pending on the underlying method. A biological genome is the structured, inherited blueprint every cell in an organism relies on. NexGenomics applies the same architectural principle to enterprise operational data — the data an organization generates is its genome, and most of it, today, is fragmented, unstructured, and ungoverned: dark data.
The real value of Genomic AI was never the cleverness of the metaphor. It's a direct, measurable reduction in what enterprises spend making their own data usable by AI systems that were never built to handle it natively — and, just as importantly, a way to verify that what those systems produce is actually right, not just fluent.
Today: One Architecture, Three Markets.
That insight now runs underneath every product NexGenomics builds. Axiom, Nexus, and Helix are applications. Genomic AI is the backbone — one governed foundation, differentiated by domain and consequence, not by the intelligence layer underneath.
Read the Full Origins Whitepaper → See What Genomic AI Is Today →
Governed to Go.
Stop rebuilding trust. Start building value.
Read the Genomic AI Whitepaper → Schedule a Discovery Workshop →